Ruwaida Begum

Leeds Teaching Hospitals NHS Trust — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index4.1kcitations168works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(71), Genetic factors in colorectal cancer(65), Colorectal Cancer Treatments and Studies(58), MicroRNA in disease regulation(31), Gastric Cancer Management and Outcomes(31)

Publications167 total

Adverse drug reaction profiles of histone deacetylase inhibitors
Scientific Reports·2025Open Access
Supplementary Figure S4 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Appendix S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S2 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S4 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Appendix S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S2 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Material S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Figure S3 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Material S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Data from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Figure S2 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S4 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S3 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Figure S3 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Data from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Figure S2 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S3 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
Supplementary Table S1 from Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study
2024Open Access
page 1 of 9Next →

Frequent Co-authors

David Cunningham(49), Ian Chau(44), Naureen Starling(36), David Watkins(26), Clare Peckitt(25), Sheela Rao(21), Andrew Wotherspoon(21), Nicola Valeri(17), Chiara Braconi(15), Francesco Sclafani(15), Andrea Lampis(13), Jens C. Hahne(13), Matteo Fassan(11), Isma Rana(11), Marco Gerlinger(11), Somaieh Hedayat(9), Janet Thomas(9), Annette Bryant(9), Katharina von Loga(9), Gayathri Anandappa(9)